配股融资超10亿港元,君实生物想拿下三张BD“王牌”?

医药魔方
16 Jun

—各奖项申报陆续启动,欢迎关注—6月13日早间,君实生物公告称,公司与独家配售代理(即瑞银集团)订立配售协议,将促使至少六名承配人,按配售价格每股H股25.35港元,认购配售不超过4100万新H股。公告显示,该配售价格较2025年6月12日在香港联交所所报收市价每股H股28.65港元折让约11.52%;较订立配售协议前最后五个连续交易日直至最后交易日在香港联交所所报平均收市价每股H股24.54港元...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10